Literature DB >> 21475232

Derailing heterotopic ossification and RARing to go.

Frederick S Kaplan, Eileen M Shore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21475232      PMCID： PMC4913781          DOI： 10.1038/nm0411-420

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

1.  A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva.

Authors:  Eileen M Shore; Meiqi Xu; George J Feldman; David A Fenstermacher; Tae-Joon Cho; In Ho Choi; J Michael Connor; Patricia Delai; David L Glaser; Martine LeMerrer; Rolf Morhart; John G Rogers; Roger Smith; James T Triffitt; J Andoni Urtizberea; Michael Zasloff; Matthew A Brown; Frederick S Kaplan
Journal:  Nat Genet       Date:  2006-04-23       Impact factor: 38.330

2.  Treatment of patients who have fibrodysplasia ossificans progressiva with isotretinoin.

Authors:  M A Zasloff; D M Rocke; L J Crofford; G V Hahn; F S Kaplan
Journal:  Clin Orthop Relat Res       Date:  1998-01       Impact factor: 4.176

3.  Bone formation and inflammation in cardiac valves.

Authors:  E R Mohler; F Gannon; C Reynolds; R Zimmerman; M G Keane; F S Kaplan
Journal:  Circulation       Date:  2001-03-20       Impact factor: 29.690

Review 4.  Inherited human diseases of heterotopic bone formation.

Authors:  Eileen M Shore; Frederick S Kaplan
Journal:  Nat Rev Rheumatol       Date:  2010-08-10       Impact factor: 20.543

5.  Conversion of vascular endothelial cells into multipotent stem-like cells.

Authors:  Damian Medici; Eileen M Shore; Vitali Y Lounev; Frederick S Kaplan; Raghu Kalluri; Bjorn R Olsen
Journal:  Nat Med       Date:  2010-11-21       Impact factor: 53.440

6.  Retinoic acid regulates bone morphogenic protein signal duration by promoting the degradation of phosphorylated Smad1.

Authors:  Nengyin Sheng; Zhihui Xie; Chen Wang; Ge Bai; Kejing Zhang; Qingqing Zhu; Jianguo Song; Francois Guillemot; Ye-Guang Chen; Anning Lin; Naihe Jing
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-18       Impact factor: 11.205

Review 7.  Applications of small molecule BMP inhibitors in physiology and disease.

Authors:  Charles C Hong; Paul B Yu
Journal:  Cytokine Growth Factor Rev       Date:  2009-11-14       Impact factor: 7.638

8.  Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-γ agonists.

Authors:  Kengo Shimono; Wei-En Tung; Christine Macolino; Amber Hsu-Tsai Chi; Johanna H Didizian; Christina Mundy; Roshantha A Chandraratna; Yuji Mishina; Motomi Enomoto-Iwamoto; Maurizio Pacifici; Masahiro Iwamoto
Journal:  Nat Med       Date:  2011-04-03       Impact factor: 53.440

9.  BMP action in skeletogenesis involves attenuation of retinoid signaling.

Authors:  Lisa M Hoffman; Kamal Garcha; Konstantina Karamboulas; Matthew F Cowan; Linsay M Drysdale; William A Horton; T Michael Underhill
Journal:  J Cell Biol       Date:  2006-07-03       Impact factor: 10.539

10.  Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative beta-catenin.

Authors:  Karen A M Kennedy; Tammy Porter; Virja Mehta; Scott D Ryan; Feodor Price; Vian Peshdary; Christina Karamboulas; Josée Savage; Thomas A Drysdale; Shun-Cheng Li; Steffany A L Bennett; Ilona S Skerjanc
Journal:  BMC Biol       Date:  2009-10-08       Impact factor: 7.364
View more
  6 in total

Review 1.  Fibrodysplasia ossificans progressiva: a blueprint for metamorphosis.

Authors:  Frederick S Kaplan; Vitali Y Lounev; Haitao Wang; Robert J Pignolo; Eileen M Shore
Journal:  Ann N Y Acad Sci       Date:  2011-11       Impact factor: 5.691

Review 2.  Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons.

Authors:  Robert J Pignolo; Eileen M Shore; Frederick S Kaplan
Journal:  Pediatr Endocrinol Rev       Date:  2013-06

3.  The skeleton in the closet.

Authors:  Frederick S Kaplan
Journal:  Gene       Date:  2013-06-25       Impact factor: 3.688

4.  Palovarotene Can Attenuate Heterotopic Ossification Induced by Tendon Stem Cells by Downregulating the Synergistic Effects of Smad and NF-κB Signaling Pathway following Stimulation of the Inflammatory Microenvironment.

Authors:  Junchao Huang; Jialiang Lin; Congbin Li; Bo Tang; Haijun Xiao
Journal:  Stem Cells Int       Date:  2022-04-28       Impact factor: 5.131

5.  From mysteries to medicines: drug development for fibrodysplasia ossificans progressive.

Authors:  Frederick S Kaplan; Robert J Pignolo; Eileen M Shore
Journal:  Expert Opin Orphan Drugs       Date:  2013-08       Impact factor: 0.694

Review 6.  Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis.

Authors:  Frederick S Kaplan; Salin A Chakkalakal; Eileen M Shore
Journal:  Dis Model Mech       Date:  2012-11       Impact factor: 5.758
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.